Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung
- PMID: 11679939
- DOI: 10.1053/hupa.2001.28248
Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung
Abstract
Large-cell neuroendocrine carcinoma (LCNEC) and small-cell lung cancer (SCLC) are high-grade neuroendocrine tumors of the lung. Despite different morphologic appearances, loss of heterozygosity and oncogene studies on LCNEC to date suggest genetic similarities. We analyzed 13 LCNEC and 5 mixed SCLC/LCNEC tumors by comparative genomic hybridization and subsequently compared our results with previously published data on 32 SCLCs. Comparison with SCLC showed several shared chromosomal aberrations, specifically losses of 3p, 4q, 5q, and 13q and gains of 5p. However, these aberrations are no special feature of neuroendocrine lung tumors but can also be found in other high-grade lung carcinomas. From this point of view, genetic similarities of LCNEC and SCLC are less important than the nonrandom changes that differ between these 2 tumor types. A gain of 3q observed in 66% of all SCLCs was detected only once in the LCNEC group. In contrast to the pure LCNEC, all mixed types with a SCLC component had a gain of 3q. Gains of 6p occurred more frequently in LCNEC. Deletions of 10q, 16q, and 17p were less frequent in LCNEC than in SCLC.
Copyright 2001 by W.B. Saunders Company
Similar articles
-
Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.Pathol Int. 2006 Aug;56(8):434-9. doi: 10.1111/j.1440-1827.2006.01985.x. Pathol Int. 2006. PMID: 16872437
-
Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.Am J Pathol. 1998 Oct;153(4):1089-98. doi: 10.1016/S0002-9440(10)65653-2. Am J Pathol. 1998. PMID: 9777940 Free PMC article. Review.
-
Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.Cancer. 2004 Mar 15;100(6):1190-8. doi: 10.1002/cncr.20108. Cancer. 2004. PMID: 15022286
-
High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.Pathol Int. 2009 Aug;59(8):522-9. doi: 10.1111/j.1440-1827.2009.02402.x. Pathol Int. 2009. PMID: 19627535
-
Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.Ann Thorac Surg. 2007 Aug;84(2):702-7. doi: 10.1016/j.athoracsur.2007.03.093. Ann Thorac Surg. 2007. PMID: 17643676 Review.
Cited by
-
Treatment of lung large cell neuroendocrine carcinoma.Tumour Biol. 2016 Jun;37(6):7047-57. doi: 10.1007/s13277-016-5003-4. Epub 2016 Mar 4. Tumour Biol. 2016. PMID: 26943800 Review.
-
Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma.Lab Invest. 2017 Aug;97(8):913-921. doi: 10.1038/labinvest.2017.36. Epub 2017 Apr 17. Lab Invest. 2017. PMID: 28414324
-
Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.Eur J Med Res. 2015 Aug 14;20(1):64. doi: 10.1186/s40001-015-0158-9. Eur J Med Res. 2015. PMID: 26272455 Free PMC article.
-
[CGH findings in neuroendocrine tumours of the lung].Pathologe. 2003 Jul;24(4):303-7. doi: 10.1007/s00292-003-0623-z. Epub 2003 May 15. Pathologe. 2003. PMID: 14513278 German.
-
CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.Virchows Arch. 2004 Nov;445(5):449-55. doi: 10.1007/s00428-004-1106-1. Epub 2004 Sep 16. Virchows Arch. 2004. PMID: 15375659
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical